Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024

Written By Van Agens
Van Agens
Previous

Longhorn Vaccines and Diagnostics to Showcase PrimeStore® Molecular Transport Medium at Two European Veterinary Health Conferences
Next

Longhorn Vaccines and Diagnostics to Present Data on LHNVD-105, a Universal Vaccine Candidate, at ECCMID 2024